CD40 and pulmonary arterial hypertension: Another study suggests that endothelial progenitor cell transplantation, a novel and experimental therapeutic option for PAH, could yield higher efficacy when turning off the CD40 pathway is turned off in the transplanted cells may have advantages in therapies used to treat PAH, namely endothelial progenitor cell transplantation (288).